These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24086245)

  • 1. Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.
    Botchkina GI; Zuniga ES; Rowehl RH; Park R; Bhalla R; Bialkowska AB; Johnson F; Golub LM; Zhang Y; Ojima I; Shroyer KR
    PLoS One; 2013; 8(9):e69884. PubMed ID: 24086245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 inhibits prostate cancer stem cell-induced tumor growth.
    Ahmad G; El Sadda R; Botchkina G; Ojima I; Egan J; Amiji M
    Cancer Lett; 2017 Oct; 406():71-80. PubMed ID: 28803993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.
    Botchkina GI; Zuniga ES; Das M; Wang Y; Wang H; Zhu S; Savitt AG; Rowehl RA; Leyfman Y; Ju J; Shroyer K; Ojima I
    Mol Cancer; 2010 Jul; 9():192. PubMed ID: 20630067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
    Kanwal R; Shukla S; Walker E; Gupta S
    Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells.
    Xie J; Mølck C; Paquet-Fifield S; Butler L; ; Sloan E; Ventura S; Hollande F
    Oncotarget; 2016 Jul; 7(28):44492-44504. PubMed ID: 27283984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
    Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
    J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
    Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.
    Shi C; Tian R; Wang M; Wang X; Jiang J; Zhang Z; Li X; He Z; Gong W; Qin R
    Cancer Biol Ther; 2010 Dec; 10(11):1182-90. PubMed ID: 20948317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
    Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
    Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
    Huang S; He P; Peng X; Li J; Xu D; Tang Y
    Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma.
    Dubrovska A; Elliott J; Salamone RJ; Kim S; Aimone LJ; Walker JR; Watson J; Sauveur-Michel M; Garcia-Echeverria C; Cho CY; Reddy VA; Schultz PG
    Clin Cancer Res; 2010 Dec; 16(23):5692-702. PubMed ID: 21138868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.
    Shimada K; Anai S; Fujii T; Tanaka N; Fujimoto K; Konishi N
    J Pathol; 2013 Dec; 231(4):495-504. PubMed ID: 24549646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.